Allegra-D Allergy and Congestion

NDC 41167-4320 · Chattem, Inc.

Generic namefexofenadine hydrochloride and pseudoephedrine hydrochloride

Dosage formTABLET, FILM COATED, EXTENDED RELEASE

RouteORAL

Active ingredient(s)FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE

Strength180; 240 mg/1; mg/1

Pharmacologic classAdrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]

Marketing categoryNDA

Packages

41167-4320-5 — 2 BLISTER PACK in 1 CARTON (41167-4320-5) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

41167-4320-7 — 3 BLISTER PACK in 1 CARTON (41167-4320-7) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

41167-4121 — fexofenadine hydrochloride, 41167-4122 — Fexofenadine Hydrochloride, 41167-4124 — fexofenadine hydrochloride, 41167-4126 — Fexofenadine Hydrochloride, 41167-4131 — fexofenadine hydrochloride, 41167-4227 — fexofenadine HCl, 41167-4232 — Fexofenadine Hydrochloride, 41167-4244 — Fexofenadine Hydrochloride, 41167-4246 — Fexofenadine Hydrochloride, 41167-4310 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 41250-417 — Naproxen sodium, Pseudoephedrine HCl, 41250-432 — Pseudoephedrine HCl, 41250-506 — Fexofenadine HCl, 41250-547 — Guaifenesin, Pseudoephedrine HCl, 41250-728 — cetirizine hydrochloride, pseudoephedrine hydrochloride, 41250-809 — pseudoephedrine hydrochloride, 41415-994 — Guaifenesin and Pseudoephedrine Hydrochloride, 41415-995 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 41520-229 — fexofenadine hcl, 41520-429 — Pseudoephedrine HCl, +483 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels